STK11 and hepatocellular carcinoma: Further analysis showed that WTAP targeted liver kinase B1 (LKB1), which in turn mediated the phosphorylation of AMP-activated protein kinase (AMPK) through m6A, thereby promoting the progression of hepatocellular carcinoma [48].